Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females
Clinical trial NCT02792517 · COMPLETED
Trial details
- NCT number
- NCT02792517
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-12
- Primary completion
- 2016-09-09
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.